184 related articles for article (PubMed ID: 1358613)
1. Visualization of posture-dependent cerebral blood flow in a patient with Takayasu's disease by means of 99mTc-HMPAO brain single photon emission tomography.
Hayashida K; Nishimura T; Hirose Y; Kaminaga T; Imakita S; Uehara T
Eur J Nucl Med; 1992; 19(11):987-9. PubMed ID: 1358613
[TBL] [Abstract][Full Text] [Related]
2. Regional differences between 99mTc-ECD and 99mTc-HMPAO SPET in perfusion changes with age and gender in healthy adults.
Inoue K; Nakagawa M; Goto R; Kinomura S; Sato T; Sato K; Fukuda H
Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1489-97. PubMed ID: 14579088
[TBL] [Abstract][Full Text] [Related]
3. A quantitative approach to technetium-99m ethyl cysteinate dimer: a comparison with technetium-99m hexamethylpropylene amine oxime.
Matsuda H; Yagishita A; Tsuji S; Hisada K
Eur J Nucl Med; 1995 Jul; 22(7):633-7. PubMed ID: 7498224
[TBL] [Abstract][Full Text] [Related]
4. Increment of brain temporal perfusion during auditory stimulation. Preliminary study with technetium-99m HMPAO SPET.
Le Scao Y; Baulieu JL; Robier A; Pourcelot L; Beutter P
Eur J Nucl Med; 1991; 18(12):981-3. PubMed ID: 1778211
[TBL] [Abstract][Full Text] [Related]
5. Brain single-photon emission tomography with technetium-99m hexamethylpropylene amine oxime in adolescents with initial-stage schizophrenia.
Batista JF; Galiano MC; Torres LA; Hernández MC; Sosa F; Perera A; Pérez M
Eur J Nucl Med; 1995 Nov; 22(11):1274-7. PubMed ID: 8575476
[TBL] [Abstract][Full Text] [Related]
6. [Raise up 99mTc-HMPAO brain SPECT for detecting the changes in cerebral perfusion pressure].
Hayashida K; Nishimura T; Uehara T; Kaminaga T; Hirose Y
Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Jul; 52(7):1036-8. PubMed ID: 1508649
[TBL] [Abstract][Full Text] [Related]
7. 18FDG PET and acetazolamide-enhanced 99mTc-HMPAO SPET in systemic lupus erythematosus.
Grünwald F; Schomburg A; Badali A; Ruhlmann J; Pavics L; Biersack HJ
Eur J Nucl Med; 1995 Sep; 22(9):1073-7. PubMed ID: 7588946
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of technetium 99m cyclobutylpropylene amine oxime as a potential brain perfusion imaging agent for SPET.
Bacciottini L; Lunghi F; Pupi A; Bonino C; Formiconi AR; De Cristofaro MT; Petti AR; Meldolesi U
Eur J Nucl Med; 1990; 17(5):242-7. PubMed ID: 2083559
[TBL] [Abstract][Full Text] [Related]
9. Cerebellar vascular response to acetazolamide in crossed cerebellar diaschisis: a comparison of 99mTc-HMPAO single-photon emission tomography with 15O-H2O positron emission tomography.
Kuwabara Y; Ichiya Y; Sasaki M; Akashi Y; Yoshida T; Fukumura T; Masuda K
Eur J Nucl Med; 1996 Jun; 23(6):683-9. PubMed ID: 8662103
[TBL] [Abstract][Full Text] [Related]
10. Does technetium-99m bicisate image local brain metabolism in late ictal temporal lobe epilepsy?
Kuikka JT; Mervaala E; Vanninen E; Kälviäinen R
Eur J Nucl Med; 1994 Nov; 21(11):1247-51. PubMed ID: 7859780
[TBL] [Abstract][Full Text] [Related]
11. Brain single-photon emission tomography with 99mTc-HMPAO in neuropsychiatric systemic lupus erythematosus: relations with EEG and MRI findings and clinical manifestations.
Colamussi P; Giganti M; Cittanti C; Dovigo L; Trotta F; Tola MR; Tamarozzi R; Lucignani G; Piffanelli A
Eur J Nucl Med; 1995 Jan; 22(1):17-24. PubMed ID: 7698150
[TBL] [Abstract][Full Text] [Related]
12. Application of technetium-99m hexamethylpropylene amine oxime single-photon emission tomography to neurologic prognosis in patients undergoing urgent carotid surgery.
Shvera IY; Cherniavsky AM; Ussov WY; Plotnikov MP; Sokolov AA; Shipulin VM; Chernov VI
Eur J Nucl Med; 1995 Feb; 22(2):132-8. PubMed ID: 7758500
[TBL] [Abstract][Full Text] [Related]
13. HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern.
Mielke R; Pietrzyk U; Jacobs A; Fink GR; Ichimiya A; Kessler J; Herholz K; Heiss WD
Eur J Nucl Med; 1994 Oct; 21(10):1052-60. PubMed ID: 7828614
[TBL] [Abstract][Full Text] [Related]
14. Vascular dementia of Binswanger's type: clinical, neuroradiological and 99mTc-HMPAO SPET study.
Shyu WC; Lin JC; Shen CC; Hsu YD; Lee CC; Shiah IS; Tsao WL
Eur J Nucl Med; 1996 Oct; 23(10):1338-44. PubMed ID: 8781138
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive measurements of regional cerebral blood flow using technetium-99m hexamethylpropylene amine oxime.
Matsuda H; Tsuji S; Shuke N; Sumiya H; Tonami N; Hisada K
Eur J Nucl Med; 1993 May; 20(5):391-401. PubMed ID: 8519258
[TBL] [Abstract][Full Text] [Related]
16. Tumour-like thallium-201 accumulation in brain infarcts, an unexpected finding on single-photon emission tomography.
Bernat I; Toth G; Kovács L
Eur J Nucl Med; 1994 Mar; 21(3):191-5. PubMed ID: 8200385
[TBL] [Abstract][Full Text] [Related]
17. In vivo metabolism and kinetics of 99mTc-HMPAO.
Lucignani G; Rossetti C; Ferrario P; Zecca L; Gilardi MC; Zito F; Perani D; Lenzi GL; Fazio F
Eur J Nucl Med; 1990; 16(4-6):249-55. PubMed ID: 2351174
[TBL] [Abstract][Full Text] [Related]
18. A multi-institutional study of interobserver agreement in the evaluation of dementia with rCBF/SPET technetium-99m exametazime (HMPAO).
Hellman RS; Tikofsky RS; Van Heertum R; Coade G; Carretta R; Hoffmann RG
Eur J Nucl Med; 1994 Apr; 21(4):306-13. PubMed ID: 8005154
[TBL] [Abstract][Full Text] [Related]
19. Benzodiazepine receptors and cerebral blood flow in partial epilepsy.
Bartenstein P; Ludolph A; Schober O; Lottes G; Scheidhauer K; Sciuk J; Beer HF
Eur J Nucl Med; 1991; 18(2):111-8. PubMed ID: 1646108
[TBL] [Abstract][Full Text] [Related]
20. Different uptake of 99mTc-ECD adn 99mTc-HMPAO in the same brains: analysis by statistical parametric mapping.
Hyun Y; Lee JS; Rha JH; Lee IK; Ha CK; Lee DS
Eur J Nucl Med; 2001 Feb; 28(2):191-7. PubMed ID: 11303889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
